SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
Clinical trial NCT05718232 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05718232
- Sponsor
- Sun Yat-sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2027-02-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.